Full history for every metric is available with a Kvantra account
Althea Group Holdings Limited (AGH.AX)
Key financial summary
Financials in AUD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | AUD m | 5 | 11 | 20 | 25 | 29 | 15 | 13 |
| Operating profit | AUD m | -2 | -2 | |||||
| Net profit | AUD m | -15 | -15 | -12 | -14 | -32 | -8 | -5 |
| EPS reported | AUD | -0.01 | -0.01 | |||||
| Operating cashflow per share | AUD | -0.01 | -0.01 | |||||
| Capex per share | AUD | 0.00 | 0.00 | |||||
| FCF per share | AUD | -0.01 | -0.01 | |||||
| Free cash flow | AUD m | -8 | -6 | |||||
| Net debt | AUD m | -0 | -0 | |||||
| Book value equity | AUD m | -1 | -1 | |||||
| Book value per share | AUD | -0.00 | -0.00 | |||||
| Number of shares | m | 556.47 | 613.4 | |||||
| DPS (TTM paid) | AUD | 0.00 | 0.00 |
Financial summary
Financials in AUD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -24.24 | -29.46 | |||||
| P/S LTM | x | 0.90 | 1.30 | |||||
| P/FCF LTM | x | -1.74 | -2.96 | |||||
| EV/EBITDA LTM | x | -7.74 | -7.88 | |||||
| EV/Sales LTM | x | 1.20 | 1.29 | |||||
| Earnings Yield LTM | % | -60.00% | -75.00% | |||||
| FCF Yield | % | -57.61% | -33.78% | |||||
| Quality | ||||||||
| ROE | % | 1454.2% | 6420.8% | |||||
| ROIC | % | -39.31% | -39.31% | |||||
| Operating margin | % | -15.50% | -15.50% | |||||
| Gross margin | % | 48.21% | 48.21% | |||||
| FCF/Sales | % | -51.72% | -51.72% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -47.30% | -47.30% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.54 | -1.10 | |||||
| Net Debt/EBITDA | x | -1.94 | -1.94 | |||||
| EBIT/Net interest | x | -3.02 | -3.02 | |||||
| Net debt/market cap | % | -0.58% | -0.47% | |||||
| Net debt/Equity | x | 0.14 | 0.14 | |||||
| Gross debt/equity | x | -9.05 | -9.05 | |||||
Company overview
Althea Group Holdings Limited is engaged in the cultivation, distribution, and sale of both therapeutic and recreational cannabis products across a global footprint, including Australia, the United Kingdom, Germany, and Canada. Beyond its product offerings, the company provides essential support services, such as educational programs, access facilitation, and treatment management, to empower eligible patients and healthcare professionals in navigating the landscape of medicinal cannabis. Althea also actively formulates and manufactures a diverse array of recreational cannabis items, ranging from beverages and edibles to concentrates and topicals. Furthermore, it owns and operates the MyAccess Clinics, a network of private medical cannabis clinics. The company was founded in Melbourne, Australia, in 2016.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Althea Group Holdings Limited (AGH.AX)
Althea Group Holdings Limited is engaged in the cultivation, distribution, and sale of both therapeutic and recreational cannabis products across a global footprint, including Australia, the United Kingdom, Germany, and Canada. Beyond its product offerings, the company provides essential support services, such as educational programs, access facilitation, and treatment management, to empower eligible patients and healthcare professionals in navigating the landscape of medicinal cannabis. Althea also actively formulates and manufactures a diverse array of recreational cannabis items, ranging from beverages and edibles to concentrates and topicals. Furthermore, it owns and operates the MyAccess Clinics, a network of private medical cannabis clinics. The company was founded in Melbourne, Australia, in 2016.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free